Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Magnesium Sarcosylate
2. Methylglycine
3. N Methylglycine
4. N-methylglycine
5. Sarcosinate, Sodium
6. Sarcosine
7. Sarcosine Hydrochloride
8. Sarcosine Monosodium Salt
9. Sarcosylate, Magnesium
1. 4316-73-8
2. Sodium 2-(methylamino)acetate
3. Sarcosine Sodium Salt
4. Sodium (methylamino)acetate
5. Sodium N-methylglycinate
6. Hamposyl Sodium Salt
7. Glycine, N-methyl-, Monosodium Salt
8. Sarcosine Monosodium Salt
9. Sarcosine, Monosodium Salt
10. Sodium N-methylaminoacetate
11. N-methylglycine, Sodium Salt
12. 6ehn3pql8z
13. 61791-59-1
14. N-methylglycine Sodium Salt
15. Sarcosinate
16. Glycine, N-methyl-, N-coco Acyl Derivs., Sodium Salts
17. Glycine, N-methyl-, N-c10-18-fatty Acyl Derivs., Sodium Salts
18. Glycine, N-methyl-, N-(c12-18-alkylsulfonyl) Derivs., Sodium Salts
19. 68411-98-3
20. 68411-99-4
21. Sodium Cocoyl Sarcosinate
22. Nsc10480
23. Nsc-10480
24. Glycine, N-methyl-, Sodium Salt
25. Einecs 224-338-5
26. Unii-6ehn3pql8z
27. Nsc 10480
28. Unii-1r9duy89cz
29. Ccris 8260
30. Amides, Coconut Oil, With Sarcosine, Sodium Salts
31. Einecs 263-193-2
32. Einecs 270-158-5
33. Me-gly-ona
34. (methylamino)acetic Acid Sodium Salt
35. Sodium Methylglycinate
36. Ec 224-338-5
37. Sodium N-cocoyl Sarcosinate
38. 1r9duy89cz
39. Schembl72880
40. Sodium2-(methylamino)acetate
41. Sodium;2-(methylamino)acetate
42. N-methylglycine Monosodium Salt
43. (c12-c18) Alkyl Sulfonamido-n-methyl Sodium Acetate
44. Dtxsid5027568
45. N-methyl-n-(c10-c18)acylaminoacetic Acid, Sodium Salt
46. N-methylglycine, Monosodium Salt
47. Sodium Sarcosinate [inci]
48. Sarcosine Sodium Salt [mi]
49. Glycine, N-methyl-, N-c10-18-fatty Acyl Derivs, Sodium Salts
50. Mfcd00068282
51. Akos006228028
52. Glycine, N-methyl-, Sodium Salt (1:1)
53. Cs-0077129
54. Ft-0635226
55. M0256
56. Sarcosine Sodium Salt (ca. 35% In Water)
57. F20742
58. A826194
59. A937124
60. W-106243
61. 7-chloro-3-methyl-benzofuran-2-carboxylicacid
62. Glycine, N-methyl-, N-coco Acyl Derivs, Sodium Salts
63. Q18212106
| Molecular Weight | 111.08 g/mol |
|---|---|
| Molecular Formula | C3H6NNaO2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 2 |
| Exact Mass | 111.02962272 g/mol |
| Monoisotopic Mass | 111.02962272 g/mol |
| Topological Polar Surface Area | 52.2 Ų |
| Heavy Atom Count | 7 |
| Formal Charge | 0 |
| Complexity | 56.9 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Market Place
ABOUT THIS PAGE
A Sodium Sarcosinate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium Sarcosinate, including repackagers and relabelers. The FDA regulates Sodium Sarcosinate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium Sarcosinate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sodium Sarcosinate supplier is an individual or a company that provides Sodium Sarcosinate active pharmaceutical ingredient (API) or Sodium Sarcosinate finished formulations upon request. The Sodium Sarcosinate suppliers may include Sodium Sarcosinate API manufacturers, exporters, distributors and traders.
Sodium Sarcosinate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sodium Sarcosinate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sodium Sarcosinate GMP manufacturer or Sodium Sarcosinate GMP API supplier for your needs.
A Sodium Sarcosinate CoA (Certificate of Analysis) is a formal document that attests to Sodium Sarcosinate's compliance with Sodium Sarcosinate specifications and serves as a tool for batch-level quality control.
Sodium Sarcosinate CoA mostly includes findings from lab analyses of a specific batch. For each Sodium Sarcosinate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sodium Sarcosinate may be tested according to a variety of international standards, such as European Pharmacopoeia (Sodium Sarcosinate EP), Sodium Sarcosinate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sodium Sarcosinate USP).
LOOKING FOR A SUPPLIER?
